Telix to Participate in UBS Global Biopharma Conference

Melbourne (Australia) and Indianapolis, IN (U.S.) | November 11, 2026

Telix will participate in the upcoming UBS Global Biopharma Conference in London (UK).

Dr. Christian Behrenbruch, Managing Director and Group CEO, and Mr. Richard Valeix, CEO Therapeutics, will take part in a fireside chat on Tuesday, November 17, 2026 at 9:20 a.m. GMT (4:20 a.m. EST, 8:20 p.m. AEDT).

The session will be webcast live, and accessible through Telix’s Investor Relations website.

For more information including how to register, please visit: https://ir.telixpharma.com/events-presentations